What does CUSIP 97382D402 represent in this 13F holders report?

CUSIP 97382D402 is the security identifier for WINT - WINDTREE THERAPEUTICS INC - COM NEW used to aggregate holder disclosures.

How many institutions held WINT - WINDTREE THERAPEUTICS INC - COM NEW in Q1 2023?

8 institutional investors reported WINT - WINDTREE THERAPEUTICS INC - COM NEW for Q1 2023. Use the holders table for investor-level position and value details.

WINDTREE THERAPEUTICS INC - COM NEW (WINT)

CUSIP: 97382D402

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / COM NEW
Total 13F shares: 2,566
Total 13F value: $12,814
Share change: +2,565
SEC-reported price per share: $5.00
Number of holders: 8
Value change: +$12,807
Number of buys: 7

Security key

97382D402

Report period

Q1 2023

Institutions

Top holders

WINT full security history Ownership snapshot Full 13F holder table WINDTREE THERAPEUTICS INC /DE/ SEC filings WINDTREE THERAPEUTICS INC /DE/ company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of WINT - WINDTREE THERAPEUTICS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Center Laboratories, Inc.

Disclosed value leader

James Huang

Comparable rows

0/15

Latest evidence

22 Feb 2023

3/4/5 13F Highest disclosed value: $3,819,976 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

James Huang has the largest disclosed position value at $3.82M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens James Huang's linked filing trail.

Disclosed position value Top 5

Center Laboratories, Inc. $2.53M

James Huang $3.82M

John P. Hamill $74.2K

RENAISSANCE TECHNOLOGIES LLC $57K

ENVESTNET ASSET MANAGEMENT INC $36.1K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Center Laboratories, Inc.	3/4/5 10%+ Owner 3/4/5	— mixed-class rows	$2,527,492 2,782,352 shares mixed-class rows	—	20 May 2020
Bioengine Capital Inc.	3/4/5 10%+ Owner 3/4/5	— mixed-class rows	— 304,176 shares mixed-class rows	—	20 May 2020
James Huang	3/4/5 Director 3/4/5	— mixed-class rows	$3,819,976 5,970,058 shares mixed-class rows	—	22 Feb 2023
John P. Hamill	3/4/5 SVP & CFO 3/4/5	— denominator unverified	$74,249 72,800 shares	—	26 Jul 2022
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— denominator unverified	$57,000 335,700 shares	—	31 Dec 2022
ENVESTNET ASSET MANAGEMENT INC	13F Company 13F	— denominator unverified	$36,080 212,236 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

2,566

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %